Content area
Full text
Background:
Diabetic macular edema (DME) is a thickening of the macula due to fluid and lipoprotein accumulation caused by blood vessel leakage.
Objective:
Aim of this study was to investigate the efficiency of aflibercept and bevacizumab in the treatment of diabetic macular edema and examine whether the expected clinical superiority of aflibercept justifies its higher price.
Methods:
The study included 159 patients who were...